2022
DOI: 10.1002/ptr.7540
|View full text |Cite
|
Sign up to set email alerts
|

Tanshinone IIA improves contextual fear‐ and anxiety‐like behaviors in mice via the CREB/BDNF/TrkB signaling pathway

Abstract: Posttraumatic stress disorder (PTSD) is one of the most common psychiatric diseases, which is characterized by the typical symptoms such as re‐experience, avoidance, and hyperarousal. However, there are few drugs for PTSD treatment. In this study, conditioned fear and single‐prolonged stress were employed to establish PTSD mouse model, and we investigated the effects of Tanshinone IIA (TanIIA), a natural product isolated from traditional Chinese herbal Salvia miltiorrhiza, as well as the underlying mechanisms … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(3 citation statements)
references
References 53 publications
0
3
0
Order By: Relevance
“…In the context of our behavioral experiments that confirm that AR significantly alleviates PTSD-like phenotype in SPS rats, these molecular studies suggest that AR’s neuroprotective effects in SPS rats may be ascribed to its positive effects on synaptic plasticity and inhibition of neuronal apoptosis. A large number of preclinical studies have investigated the therapeutic effects of drugs or other therapeutic strategies on PTSD symptoms by studying changes in synaptic plasticity and neuronal apoptosis ( Li et al, 2013 ; Ji et al, 2019 ; Feng et al, 2020 ; Jiang et al, 2022 ; Li et al, 2022 ): e.g., Sevoflurane has been shown to attenuate apoptosis and improve synaptic plasticity in the hippocampus of rat models of PTSD ( Gu et al, 2023 ), and down-regulating MiR-153 has been observed to alleviate PTSD-like behaviors by affecting synaptic plasticity and apoptosis ( Chen et al, 2022 ). Hence, the present findings that AR enhances synaptic plasticity and inhibits neuronal apoptosis suggest that it has potential as an effective therapeutic agent in the treatment of PTSD.…”
Section: Discussionmentioning
confidence: 99%
“…In the context of our behavioral experiments that confirm that AR significantly alleviates PTSD-like phenotype in SPS rats, these molecular studies suggest that AR’s neuroprotective effects in SPS rats may be ascribed to its positive effects on synaptic plasticity and inhibition of neuronal apoptosis. A large number of preclinical studies have investigated the therapeutic effects of drugs or other therapeutic strategies on PTSD symptoms by studying changes in synaptic plasticity and neuronal apoptosis ( Li et al, 2013 ; Ji et al, 2019 ; Feng et al, 2020 ; Jiang et al, 2022 ; Li et al, 2022 ): e.g., Sevoflurane has been shown to attenuate apoptosis and improve synaptic plasticity in the hippocampus of rat models of PTSD ( Gu et al, 2023 ), and down-regulating MiR-153 has been observed to alleviate PTSD-like behaviors by affecting synaptic plasticity and apoptosis ( Chen et al, 2022 ). Hence, the present findings that AR enhances synaptic plasticity and inhibits neuronal apoptosis suggest that it has potential as an effective therapeutic agent in the treatment of PTSD.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, this pathway has been considered a target for a drug investigation. Several compounds or extracts from natural products, such as darmmarane sapogenins originating from ginseng ( Jiang et al, 2020 ), tannins from Terminalia chebula fruits ( Chandrasekhar et al, 2018 ), and diterpene quinone Tanshinone IIA isolated from the roots of Salvia miltiorrhiza Bunge ( Jiang et al, 2022 ), attenuate anxiety by activating the CREB/BDNF pathways. Flavonoids are also reported to attenuate mental disorders involved in CREB/BDNF pathway, such as rutin ( Moghbelinejad et al, 2014 ), baicalin ( Jia et al, 2021 ), and naringin ( Gao et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, HPA axis dysfunction caused by endocrine disorders is an inducing or aggravating factor for anxiety ( 93 95 ). Recent studies have shown that regulating FGFR can affect BDNF expression ( 96 ) and that the BDNF-TrkB signaling pathway plays an important role in anxiety ( 96 , 97 ). The overexpression of serum CDCA over-activates intestinal FXR receptors, resulting in an imbalance in the FGFs/FGFRs system that impacts the BDNF-TrkB signal pathway, which finally culminates in anxiety-like behavior.…”
Section: Signal Transduction Of Bile Acids and Their Receptors In Pat...mentioning
confidence: 99%